Unfabled, a London, UK-based provider of a platform for women’s health and wellbeing, raised $1.6M in Seed funding.
The round, which brought the total amount to $2M, saw participation from Morgan Stanley, Exceptional Ventures, Atomico Angels, Founders Factory, Chai Ventures, Syndicate Room, and 3 Sisters Ventures. Angel investors also joined from across technology and healthcare. They included Maya Ghosn (a scout for Sequoia) Shefali Roy (Apple, TrueLayer), Elaine Groenestein (first angel at Elvie), and Fiona Pathiraja.
The company intends to use the funds to expand the platform, as well as develop its in-house data science, a core element of its B2B offering.
Founded in 2021 by Hannah Samano (ex-Unilever, Kasha), Unfabled is a data-driven health platform that delivers curated and personalised solutions for women. After answering a series of questions about their hormonal and health priorities, it provides users with a curated selection of products to support their needs. Over 300,000 people are using Unfabled to discover effective treatments for a range of conditions, from menstrual cramps to pregnancy and menopause.
Commenting on the news, Hannah Samano said: “Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause.”
FinSMEs